1. 中国中医科学院医学实验中心,北京市中医药防治重大疾病基础研究重点实验室
2. 湖北中医药大学药学院
3. 中国中医科学院西苑医院
纸质出版:2014
移动端阅览
[1]杨伟峰,陈靓,崔海峰,李连达,郝伟,雷洪涛.补肾活血方对急性心肌梗死大鼠早期心功能及内皮素-1、血管紧张素Ⅱ的影响[J].中医杂志,2014,55(24):2139-2142.
YANG Weifeng, CHEN Liang, CUI Haifeng, et al. Experimental Study of Bushen Huoxue Formula on Cardiac Function,ET-1 and Ang Ⅱ in Rat Models of Acute Myocardial Infarction in Early Phrase[J]. Journal of Traditional Chinese Medicine2014, 55(24): 2139-2142.
[1]杨伟峰,陈靓,崔海峰,李连达,郝伟,雷洪涛.补肾活血方对急性心肌梗死大鼠早期心功能及内皮素-1、血管紧张素Ⅱ的影响[J].中医杂志,2014,55(24):2139-2142. DOI: 10.13288/j.11-2166/r.2014.24.018.
YANG Weifeng, CHEN Liang, CUI Haifeng, et al. Experimental Study of Bushen Huoxue Formula on Cardiac Function,ET-1 and Ang Ⅱ in Rat Models of Acute Myocardial Infarction in Early Phrase[J]. Journal of Traditional Chinese Medicine2014, 55(24): 2139-2142. DOI: 10.13288/j.11-2166/r.2014.24.018.
目的观察补肾活血方对急性心肌梗死(AMI)大鼠早期心功能的影响并探讨其可能作用机制。方法将60只Wistar大鼠随机分为模型组、假手术组、阳性药组及补肾活血方高、中、低剂量组
每组10只。除假手术组外其余大鼠采用冠状动脉结扎法建立AMI大鼠模型。阳性药组予依那普利0.2 g/(kg·d)灌胃
补肾活血方高、中、低剂量组分别予补肾活血方生药10、5、2.5 g/(kg·d)灌胃
假手术组与模型组予等量生理盐水灌胃。14天后
采用高分辨率超声影像系统测量大鼠左心室舒张末期前壁厚度(LVAWd)与后壁厚度(LVPWd)、左室舒张末期内径(LVIDd)和收缩末期内径(LVIDs)
计算左室舒张末期和收缩末期容积(LVEDV
LVESV)及射血分数(EF)、短轴缩短率(FS)、每搏输出量(SV)
评价各组大鼠心脏结构和功能变化。ELISA法检测各组大鼠血清内皮素-1(ET-1)、血管紧张素Ⅱ(AngⅡ)水平。结果与模型组比较
补肾活血方各剂量组LVAWd均显著升高(P<0.05或P<0.01)
LVIDs、LVIDd、LVEDV呈现减小趋势但差异无统计学意义(P>0.05);补肾活血方高剂量组与阳性药组EF、FS显著升高(P<0.01);补肾活血方各剂量组血清AngⅡ水平明显下降(P<0.01)
ET-1水平呈现减小趋势但差异无统计学意义(P>0.05)。结论补肾活血方可在心肌梗死早期调节心室重构、改善心脏功能
其机制与调节Ang II、ET-1水平有关。
Objective To investigate the influence of Bushenhuoxue formula on cardiac function in rat models of acute myocardial infarction( AMI) and its possible mechanism. Method Sixty Wistar rats were randomly divided into six groups
which were the sham-operation group
AMI model group
positive drug control group
and high-dose
medium-dose and low-dose Bushenhuoxue formula groups. The rat models of myocardial infarction were established by ligation of the anterior descending coronary artery in all groups except for sham-operation group. The high-dose
medium-dose and low-dose Bushenhuoxue formula groups were gavaged with 10 g /( kg·d)
5 g /( kg·d)
or 2. 5 g /( kg·d) of crude drug of Bushenhuoxue formula
respectively; The positive drug control group was gavaged with 0.2 g /( kgd) of enalapril; and both the sham-operation group and AMI model group were give the same volume of saline. 14 days after treatment
thickness of left ventricular anterior and posterior wall at end-diastole( LVAWd and LVPWd)
as well as left ventricular internal dimension at end-diastole and end of systole( LVIDd and LVIDs) were measured with high resolution ultrasound imaging system. Left ventricular end diastolic volume( LVEDV)
left ventricular end systolic volume( LVESV)
ejection fraction( EF)
fractional shortening( FS)
and systolic volume( SV) were calculated to assess the change in structure and function of rat hearts in each group. Serum levels of angiotensin Ⅱ( Ang Ⅱ) and endothelin-1( ET-1) were detected with enzyme-linked immunosorbent assay( ELISA).Result Compared with the model group
LVAWd increased significantly( P < 0. 05 or P < 0. 01)
and LVIDd and LVEDV showed a trend of decrease but with no significant difference( P > 0. 05) in all Bushenhuoxue formula groups; Levels of EF and FS were increased significantly in Bushenhuoxue formula high dose group and positive drug control group( P < 0. 01); Levels of Ang Ⅱ was reduced significantly( P < 0. 01); and levels of ET-1 showed a downward trend but with no significant difference in all Bushenhuoxue formula groups( P > 0. 05). Conclusion Bushenhuoxue formula can inhibit left ventricular remodeling and improve heart function by reducing level of Ang Ⅱand adjusting the level of ET-1 in early phrase of acute myocardial infarction.
0
浏览量
180
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号